Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedAug 21, 2013Acetylcysteine Ophthalmic SolutionLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-857-2013Class IITerminatedAug 14, 2013Zolpidem Tartrate Tablets 5 mgUnit Dose Mispackaging: This recall event is due to a random undetected packaging issue which could increase the potential for a small number of individual unit dose...American Health Packaging · D-856-2013Class IIITerminatedAug 14, 2013BuPROPion Hydrochloride Extended-Release TabletsFailed Dissolution Specifications: Dissolution test results at 8 hour time-point were above approved specification limits.Actavis Inc · D-855-2013Class IIITerminatedAug 14, 2013IntrovaleContraceptive tablets out of sequence: Contraceptive tablets out of sequence: Introvale (levonorgestrel and ethinyl estradiol tablets USP 0.15mg/0.03mg) is voluntarily...Sandoz Incorporated · D-854-2013Class IITerminatedAug 14, 2013Lisinopril TabletsFailed Impurities/Degradation Specifications: Out of Specification results for Individual Other Unknown Related Compounds were obtained at the 48 month time-point.West-Ward Pharmaceutical Corp. · D-853-2013Class IITerminatedAug 14, 2013Latanoprost Ophthalmic SolutionLack of Assurance of Sterility: Failed at expiry for Preservative Effectiveness Test (PET), therefore the product may be susceptible to microbial growth before the...Apotex Inc · D-852-2013Class IITerminatedAug 14, 2013Ondansetron InjectionPresence of Particulate; lot being recalled as a precaution due to the discovery of 2 particles found in a lot which preceded the recalled lotHospira, Inc. · D-851-2013Class IIITerminatedAug 14, 2013TUMS, Antacid/Calcium SupplementPresence of Foreign Tablets/Capsules: Product labeled TUMS Ultra Assorted Berries 1000mg Chewable tables, may contain EX TUMS Assorted Berries 750mg tabletsGlaxoSmithKline, LLC. · D-850-2013Class IITerminatedAug 14, 2013Methylphenidate Hydrochloride Extended-Release CapsulesFailed Dissolution Specifications: Product is being recalled due to out of specification dissolution results obtained during routine stability testing.Teva Pharmaceuticals USA, Inc. · D-849-2013Class IITerminatedAug 14, 2013Methylphenidate Hydrochloride Extended-Release CapsulesFailed Dissolution Specifications: Product is being recalled due to out of specification dissolution results obtained during routine stability testing.Teva Pharmaceuticals USA, Inc. · D-848-2013Class IITerminatedAug 14, 2013Methylphenidate Hydrochloride Extended-Release CapsulesFailed Dissolution Specifications: Product is being recalled due to out of specification dissolution results obtained during routine stability testing.Teva Pharmaceuticals USA, Inc. · D-847-2013Class IITerminatedAug 14, 2013Parsel PlusDefective container: products are packaged in pouches which may not have been fully sealedNovartis Consumer Health · D-846-2013Class IITerminatedAug 14, 2013No Doz, Max StrengthDefective container: products are packaged in pouches which may not have been fully sealedNovartis Consumer Health · D-845-2013Class IITerminatedAug 14, 2013Excedrin MigraineDefective container: products are packaged in pouches which may not have been fully sealedNovartis Consumer Health · D-844-2013Class IITerminatedAug 14, 2013Excedrin Extra StrengthDefective container: products are packaged in pouches which may not have been fully sealedNovartis Consumer Health · D-843-2013Class IITerminatedAug 14, 2013Terazosin Hydrochloride CapsulesLabeling -label error on declared strength: unopened, sealed bottle of Terazosin Hydrochloride (HCl) 10mg Capsules contained Terazosin HCl 5 mg CapsulesTeva Pharmaceuticals USA, Inc. · D-842-2013Class IITerminatedAug 14, 2013Rifadin, Rifampin capsulesSubpotent drug: low fill volume in some of the capsulesSanofi US · D-841-2013Class IITerminatedAug 14, 2013MERREM I.VPresence of Precipitate; potential for incomplete constitution upon addition of diluent.AstraZeneca Pharmaceuticals LP · D-840-2013Class IITerminatedAug 14, 2013VersaPharm IncorporatedDiscoloration: Ethambutol HCl Tablets 400 mg is being recalled due to a Out of Specification result for description testing for a surface defect of ink.West-Ward Pharmaceutical Corp. · D-839-2013Class ITerminatedAug 14, 2013Warfarin Sodium TabletsFailed Tablet/Capsule Specifications: A product complaint was received from a pharmacist who discovered that 3 tablets in a 1000-count bottle were oversized.Zydus Pharmaceuticals USA Inc · D-838-2013Class ITerminatedAug 14, 2013Reumofan PlusMarketed without an approved NDA/ANDA: Product may contain undeclared active pharmaceutical ingredients Diclofenac Sodium, Dexamethasone, and Methocarbamol.Reumofan Plus USA · D-837-2013Class ITerminatedAug 14, 20130.9% Sodium Chloride InjectionPresence of Particulate Matter: reports of small grey/brown particles found in the primary container identified as brass particulatesHospira Inc. · D-836-2013Class ITerminatedAug 14, 2013Piperacillin and Tazobactam for InjectionCrystallization: Potential to exhibit precipitation/crystallization in IV bag or IV line upon reconstitution.Apotex Corp. · D-835-2013Class ITerminatedAug 14, 2013Lightning ROD capsulesMarketed Without An Approved NDA/ANDA: Lightning Rod capsules are being recalled because FDA analysis found it to contain an undeclared analogue of sildenafil...Chang Kwung Products · D-834-2013Class ITerminatedAug 14, 2013Lightning ROD capsulesMarketed Without An Approved NDA/ANDA: Lightning Rod capsules are being recalled because FDA analysis found it to contain an undeclared analogue of sildenafil...Chang Kwung Products · D-833-2013Class ITerminatedAug 14, 2013Methotrexate InjectionPresence of Particulate Matter: Found during examination of retention samples.Sandoz Incorporated · D-832-2013Class IITerminatedAug 7, 2013DIANEAL Low CalciumDefective Container: There is a potential for frangible components to be broken, resulting in a leak at the port when the closure is removed.Baxter Healthcare Corp. · D-831-2013Class IITerminatedAug 7, 2013Olanzapine TabletsDefective Container; This action is being taken as a precautionary measure due to the product being re-packaged in the U.S. using a filler material that (removes or...Torrent Pharma Inc · D-830-2013Class IITerminatedAug 7, 2013Ranitidine SyrupFailed Impurity/Degradation Specification; "Related Compound C"Actavis South Atlantic LLC · D-829-2013Class ITerminatedAug 7, 2013Night Bullet CapsulesMarketed Without an Approved NDA/ANDA; product contains analogues of sildenafil and tadalafil which are active pharmaceutical ingredients in FDA-approved drugs used to...Green Planet Inc · D-828-2013Class IITerminatedAug 7, 2013DayQuil Sinex DayTime Sinus ReliefUnit Dose Mispackaging: Product packaging defect which could result in code date smearing, incomplete blister card cuts, and missing or incorrectly placed liquicaps...Procter & Gamble Co · D-827-2013Class IITerminatedAug 7, 2013Belladonna Alkaloids/PBPresence of Foriegn Substance:The manufacturer, West-ward Pharmaceutical, recalled product because of the presence of black spots on tablets. In response, the repackager...Physicians Total Care, Inc. · D-826-2013Class IITerminatedAug 7, 2013EnablexFailed Impurities/Degradation Specifications: unspecified degradation productWarner Chilcott US LLC · D-822-2013Class IITerminatedJul 31, 2013West-ward Belladonna Alkaloids with Phenobarbital TabletsCross contamination with other products: Belladonna Alkaloids with Phenobarbital Tablets contained a trace amount of Methocarbamol.West-Ward Pharmaceutical Corp. · D-825-2013Class IITerminatedJul 31, 2013West-ward Belladonna Alkaloids with Phenobarbital TabletsPresence of Foreign Substance: Belladonna Alkaloids with Phenobarbital Tablets with black specks comprised of degraded organic material on tablets.West-Ward Pharmaceutical Corp. · D-824-2013Class IIITerminatedJul 31, 2013Oxycodone and Acetaminophen CapsulesSubpotent drug: Two lots of Oxycodone and Acetaminophen Capsules, USP 5/500 mg are being recalled due to low out of specification (OOS) assay result obtained at expiry...Watson Laboratories Inc · D-823-2013Class IITerminatedJul 31, 2013AmBisomeLack of Sterility Assurance; During a routine simulation of the manufacturing of AmBisome, a bacterial contamination was detected in some media fill units. No...Gilead Sciences, Inc. · D-821-2013Class IITerminatedJul 31, 2013AmBisomeLack of Assurance of Sterility; Astellas Pharma US, Inc. is performing a voluntary recall on certain lots of AmBisome because the manufacturer has notified Astellas that...Astellas Pharma US Inc · D-820-2013Class IITerminatedJul 31, 2013VIVITROLLack of Assurance of Sterility: Product did not meet the criteria for container closure integrity testing during routine 24 month stability testing.Alkermes, Inc. · D-819-2013Class IITerminatedJul 31, 2013Oxygen, Compressed USP UN1072 Medical Gas supplied in a) 682 litres and b)165 litres cylindersFailed impurities/degradation specifications: Purity readings for oxygen were out of specification.Oklahoma Respiratory Care Inc · D-818-2013

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.